Beth A. Taylor
CIK 1522046 · Chief Financial Officer · last filed 2026-02-19
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$11.6K
Companies
3
Total Filings
34
Lifetime Open-Market Net
$12.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NOTV | Chief Financial Officer | 145,480 | $0.08 | $11.6K | $137.7K | 15 | 2026-02-19 |
| Inotiv, Inc. (BASI) Delisted | VP- Finance & CFO | 34,295 | $16.44 | $563.8K | $147.4K | 4 | 2021-03-05 |
| ENDOCYTE INC (ECYT) Delisted | VP Finance & Chief Acctg Off | 0 | — | — | -$272.3K | 15 | 2018-12-21 |
Recent Filings · Page 4 of 4
34 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-02-06 | ENDOCYTE INC (ECYT) Delisted | Mixed | +3,975 | -$2.7K | EDGAR |
| 2014-02-10 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | +5,425 | $0 | EDGAR |
| 2013-02-21 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-03-02 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 31–34 of 34
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.